RN7SKP82

Across TCGA pan-cancer cohorts, RN7SKP82 RNA is linked to patient survival in 8 of 34 cancer types, making it the most broadly survival-associated RN7SKP82 data layer.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher RN7SKP82 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RN7SKP82 expression acts as an unfavorable survival marker, although some lineages such as HNSC show a favorable association.

LUAD, STAD, and UCEC are the cancer types where RN7SKP82 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	DFS	Tertile	All	0.206	0.791	.001	63	view →
STAD	DFS	Tertile	II,III,IV	0.283	0.714	<.001	54	view →
UCEC	DFS	Tertile	All	0.763	0.901	.001	54	view →
KIRC	DFS	Tertile	II,III,IV	0.002	0.762	<.001	42	view →
ESCA	OS	Tertile	All	0.207	0.911	.001	36	view →
HNSC	DFS	Tertile	III,IV	1.000	0.652	.025	27	view →
BLCA	OS	Tertile	All	0.249	0.709	.042	18	view →
KIRP	OS	Tertile	All	0.314	0.715	.045	6	view →

Pink = unfavorable, green = favorable. Showing the 8 strongest of 8 lineages.

RN7SKP82–LUAD (DFS)

Open the LUAD breakdown →